Advertisement
Canada markets closed
  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CAD/USD

    0.7266
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    82.75
    +0.06 (+0.07%)
     
  • Bitcoin CAD

    84,929.40
    -3,286.78 (-3.73%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,382.20
    -6.20 (-0.26%)
     
  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     
  • 10-Yr Bond

    4.5850
    -0.0740 (-1.59%)
     
  • NASDAQ futures

    17,696.25
    +37.75 (+0.21%)
     
  • VOLATILITY

    18.21
    -0.19 (-1.03%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • NIKKEI 225

    37,820.76
    -141.04 (-0.37%)
     
  • CAD/EUR

    0.6805
    +0.0003 (+0.04%)
     

Stocks in play: InMed Pharmaceuticals Inc.

Has filed Clinical Trial Applications in Austria, Israel and Serbia as part of a Phase 2 clinical trial of INM-755 (cannabinol) cream in Epidermolysis Bullosa. Additional CTAs for 755-201-EB (the ‘201 study) will be submitted to National Competent Authorities and Ethics Committees in France, Germany, Greece, and Italy in the coming weeks. InMed Pharmaceuticals Inc. shares T.IN are trading up $0.33 at $4.39.

Read: